On July 15, Cigna declined 3.4% in regular trading, trading at approximately $294.92/share, with turnover of $14.12 million. The stock retreated alongside a sector-wide selloff in healthcare names.

The healthcare sector saw broad-based weakness, with Molina Healthcare leading losses at -6.5%, Centene declining 3.8%, UnitedHealth falling 1.9%, CVS Health dropping 1.8%, and Humana losing 1.6%. Cigna moved in sympathy with this collective downturn, reversing gains from earlier in the week when the stock had risen over 3% following Bernstein's target price increase to $381 from $371 with an outperform rating maintained.

Fundamentally, Cigna reported Q1 adjusted EPS of $7.79, beating estimates by 2.4%, and raised full-year guidance to at least $30.35 per share. The next earnings report is scheduled for July 30 pre-market, with consensus EPS expectations of $7.58. Morgan Stanley has previously noted managed-care companies including Cigna could benefit from improving utilization trends and AI-driven efficiency gains.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)